Role of long non-coding RNA MALAT1 in the development and progression of hepatocellular carcinoma

Yongkang SUN; Xuebo YAN; Zemin ZHU; Dingcheng SHEN; Zhiqin XIE; Zhijian ZHAO; Caixi TANG

doi:10.3969/j.issn.1001-5256.2021.03.041

Volume 37 Issue 3

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(3): 704-708

PDF( 1820 KB)

Role of long non-coding RNA MALAT1 in the development and progression of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.03.041

Department of Hepatobiliary and Pancreatosplenic Surgery, Affiliated Zhuzhou Hospital, Xiangya Medical College, Central South University, Zhuzhou, Hunan 412007, China

Received Date: 2020-09-08
Accepted Date: 2020-10-20
Published Date: 2021-03-20

Abstract

Abstract

Hepatocellular carcinoma (HCC) has the features of high incidence rate, low survival rate, poor treatment outcome, and complex pathogenesis. In recent years, many studies have shown that long non-coding RNA (lncRNA) MALAT1 is upregulated in HCC and can promote the proliferation, invasion, and metastasis of HCC cells, and it can also guide the diagnosis, prognostic evaluation, and treatment of HCC in clinical practice. This article reviews the current status of research on lncRNA MALAT1 in HCC and discusses its expression pattern, mechanism of action, and clinical significance in predicting and monitoring the progression of HCC, so as to gain a deep understanding of the role of lncRNA MALAT1 in the progression of HCC. It is pointed out that lncRNA MALAT1 is expected to become a potential biomarker for the diagnosis and prognostic evaluation of HCC and may be used as a therapeutic target in clinical practice.
- Carcinoma, Hepatocellular,
- RNA, Long Noncoding,
- Metastasis-Associated Lung Adenocarcinoma Transcript 1

FullText(HTML)

References(39)

References

[1]	ZHAO ZB, CHEN F, BAI XF. Long noncoding RNA MALAT1 regulates hepatocellular carcinoma growth under hypoxia via sponging microRNA-200a[J]. Yonsei Med J, 2019, 60(8): 727-734. DOI: 10.3349/ymj.2019.60.8.727
[2]	CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338
[3]	CHEN S, WANG G, TAO K, et al. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis[J]. Cancer Sci, 2020, 111(5): 1582-1595. DOI: 10.1111/cas.14372
[4]	HE B, PENG F, LI W, et al. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling[J]. J Cell Biochem, 2019, 120(3): 2908-2918. DOI: 10.1002/jcb.26823
[5]	HAN SK, LI ZM, HAN B, et al. Expression of long non-coding RNA MALAT1 in hepatocellular carcinoma tissue and its actions on proliferation and invasion/metastasis of hepatocellular carcinoma cells[J]. Chin J Gen Surg, 2018, 27(1): 49-54. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201801012.htm 韩树坤, 李忠民, 韩冰, 等. 长链非编码RNA MALAT1在肝癌组织中的表达及其在肝癌细胞增殖与侵袭转移中的作用[J]. 中国普通外科杂志, 2018, 27(1): 49-54. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201801012.htm
[6]	PENG N, HE J, LI J, et al. Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis[J]. Cancer Cell Int, 2020, 20: 165. DOI: 10.1186/s12935-020-01231-w
[7]	MALAKAR P, STEIN I, SARAGOVI A, et al. Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2[J]. Cancer Res, 2019, 79(10): 2480-2493. DOI: 10.1158/0008-5472.CAN-18-1432
[8]	LI ZX, ZHU QN, ZHANG HB, et al. MALAT1: A potential biomarker in cancer[J]. Cancer Manag Res, 2018, 10: 6757-6768. DOI: 10.2147/CMAR.S169406
[9]	YU Q, XIANG L, CHEN Z, et al. MALAT1 functions as a competing endogenous RNA to regulate SMAD5 expression by acting as a sponge for miR-142-3p in hepatocellular carcinoma[J]. Cell Biosci, 2019, 9: 39. DOI: 10.1186/s13578-019-0299-6
[10]	YUAN LT, CHANG JH, LEE HL, et al. Genetic variants of lncRNA MALAT1 exert diverse impacts on the risk and clinicopathologic characteristics of patients with hepatocellular carcinoma[J]. J Clin Med, 2019, 8(9): 1406. DOI: 10.3390/jcm8091406
[11]	ZHANG X, HAMBLIN MH, YIN KJ. The long noncoding RNA Malat1: Its physiological and pathophysiological functions[J]. RNA Biol, 2017, 14(12): 1705-1714. DOI: 10.1080/15476286.2017.1358347
[12]	LAI MC, YANG Z, ZHOU L, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation[J]. Med Oncol, 2012, 29(3): 1810-1816. DOI: 10.1007/s12032-011-0004-z
[13]	YAO K, ZHANG GJ, HUANG ZM, et al. Long non-coding RNA MALAT1 expression in hepatocellular carcinoma and its action[J]. Chin J Gen Surg, 2016, 25(1): 90-96. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201601020.htm 姚凯, 张光军, 黄忠明, 等. 长链非编码RNA MALAT1在肝癌中表达及功能研究[J]. 中国普通外科杂志, 2016, 25(1): 90-96. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201601020.htm
[14]	HUANG Z, HUANG L, SHEN S, et al. Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma[J]. Oncol Rep, 2015, 34(5): 2403-2412. DOI: 10.3892/or.2015.4259
[15]	WANG J, WANG H, ZHANG Y, et al. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer[J]. Cell Signal, 2014, 26(5): 1048-1059. DOI: 10.1016/j.cellsig.2014.01.022
[16]	LI C, CHANG L, CHEN Z, et al. The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration[J]. Int J Mol Med, 2017, 39(2): 347-356. DOI: 10.3892/ijmm.2017.2854
[17]	FAN L, HUANG X, CHEN J, et al. Long noncoding RNA MALAT1 contributes to sorafenib resistance by targeting miR-140-5p/Aurora-A signaling in hepatocellular carcinoma[J]. Mol Cancer Ther, 2020, 19(5): 1197-1209. DOI: 10.1158/1535-7163.MCT-19-0203
[18]	MALAKAR P, SHILO A, MOGILEVSKY A, et al. Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation[J]. Cancer Res, 2017, 77(5): 1155-1167. DOI: 10.1158/0008-5472.CAN-16-1508
[19]	LIU D, ZHU Y, PANG J, et al. Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195[J]. J Cell Biochem, 2018, 119(2): 1368-1380. DOI: 10.1002/jcb.26297
[20]	CHEN L, YAO H, WANG K, et al. Long non-coding RNA MALAT1 regulates ZEB1 expression by sponging miR-143-3p and promotes hepatocellular carcinoma progression[J]. J Cell Biochem, 2017, 118(12): 4836-4843. DOI: 10.1002/jcb.26158
[21]	HOU Z, XU X, FU X, et al. HBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma[J]. Am J Cancer Res, 2017, 7(4): 845-856.
[22]	LI Y, ZHANG X, ZHENG Q, et al. YAP1 inhibition in HUVECs is associated with released exosomes and increased hepatocarcinoma invasion and metastasis[J]. Mol Ther Nucleic Acids, 2020, 21: 86-97. DOI: 10.1016/j.omtn.2020.05.021
[23]	LIU S, QIU J, HE G, et al. LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression[J]. J Cancer, 2019, 10(26): 6649-6659. DOI: 10.7150/jca.29213
[24]	CUI RJ, FAN JL, LIN YC, et al. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma[J]. Cancer Med, 2019, 8(14): 6358-6369. DOI: 10.1002/cam4.2482
[25]	PAN Y, TONG S, CUI R, et al. Long non-coding MALAT1 functions as a competing endogenous RNA to regulate vimentin expression by sponging miR-30a-5p in hepatocellular carcinoma[J]. Cell Physiol Biochem, 2018, 50(1): 108-120. DOI: 10.1159/000493962
[26]	LI C, MIAO R, LIU S, et al. Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis[J]. Oncotarget, 2017, 8(17): 28683-28695. DOI: 10.18632/oncotarget.15640
[27]	HOU Z, XU X, ZHOU L, et al. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1[J]. Tumour Biol, 2017, 39(7): 1010428317718135.
[28]	HOU ZH, XU XW, FU XY, et al. Long non-coding RNA MALAT1 promotes angiogenesis and immunosuppressive properties of HCC cells by sponging miR-140[J]. Am J Physiol Cell Physiol, 2020, 318(3): c649-c663. DOI: 10.1152/ajpcell.00510.2018
[29]	ZHANG P, HA M, LI L, et al. MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway[J]. FASEB J, 2020, 34(1): 66-81. DOI: 10.1096/fj.201901834R
[30]	DUAN YF, ZHAO QX, JING X. Effect of long non-coding RNAs on glycolytic pathway in primary liver cancer and related mechanisms[J]. J Clin Hepatol, 2019, 35(6): 1374-1376. DOI: 10.3969/j.issn.1001-5256.2019.06.043 段艺菲, 赵清喜, 荆雪. 长链非编码RNA对原发性肝癌中糖酵解途径的影响机制[J]. 临床肝胆病杂志, 2019, 35(6): 1374-1376. DOI: 10.3969/j.issn.1001-5256.2019.06.043
[31]	HUANG M, WANG H, HU X, et al. lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression[J]. Oncoimmunology, 2019, 8(1): e1518628. DOI: 10.1080/2162402X.2018.1518628
[32]	CHEN L, KONG R, WU C, et al. Circ-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells[J]. Adv Sci (Weinh), 2019, 7(4): 1900949.
[33]	WANG C, ZHANG Q, HU Y, et al. Emerging role of long non-coding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A meta-analysis[J]. Oncol Lett, 2019, 17(2): 2159-2170. http://www.onacademic.com/detail/journal_1000041698573399_a18c.html
[34]	TORAIH EA, ELLAWINDY A, FALA SY, et al. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma[J]. Biomed Pharmacother, 2018, 102: 653-669. DOI: 10.1016/j.biopha.2018.03.105
[35]	LIU F, LI T, ZHANG L, et al. PAMAM/polyhedral nanogold-modified probes with DNAase catalysis for the amperometric electrochemical detection of metastasis-associated lung adenocarcinoma transcript?[J]. J Biol Eng, 2019, 13: 21. DOI: 10.1186/s13036-019-0149-4
[36]	LIU XQ, WANG X, LIU C, et al. Expression and clinical significance of long chain non-coding MALAT1 RNA in patients with hepatocellular carcinoma[J]. Tianjin Med J, 2016, 44(12): 1484-1488. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYZ201612020.htm 刘兴强, 王霞, 刘超, 等. 长链非编码RNA MALAT1在肝细胞癌行肝切除患者中的表达及临床意义[J]. 天津医药, 2016, 44(12): 1484-1488. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYZ201612020.htm
[37]	JI DG, GUAN LY, LUO X, et al. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway[J]. Biochem Biophys Res Commun, 2018, 501(1): 33-40. DOI: 10.1016/j.bbrc.2018.04.116
[38]	YUAN P, CAO W, ZANG Q, et al. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy[J]. Biochem Biophys Res Commun, 2016, 478(3): 1067-1073. DOI: 10.1016/j.bbrc.2016.08.065
[39]	CHANG HL, BAMODU OA, ONG JR, et al. Targeting the epigenetic non-coding RNA MALAT1/Wnt signaling axis as a therapeutic approach to suppress stemness and metastasis in hepatocellular carcinoma[J]. Cells, 2020, 9(4): 1020. DOI: 10.3390/cells9041020

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (628) PDF downloads(49)

Role of long non-coding RNA MALAT1 in the development and progression of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.03.041

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Role of long non-coding RNA MALAT1 in the development and progression of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.03.041

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content